Healthcare & Life Sciences
Lysosomal Therapeutics, Inc.
United States
series-a
series-a
Stage
1
Investors
About
Lysosomal Therapeutics, Inc. is a biotechnology company that develops therapies targeting lysosomal biology to treat lysosomal and related diseases.
Explore Lysosomal Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.